Allarity Therapeutics, Inc. Other Nonoperating Income (Expense)
Allarity Therapeutics, Inc. (ALLR) reported Other Nonoperating Income (Expense) of -$21.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2023-11-14
- Allarity Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2023-09-30 was -$21.00K.
- Allarity Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2023-06-30 was $1.78M.
- Allarity Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2023-03-31 was $307.00K, a 97.81% decline year-over-year.
- Allarity Therapeutics, Inc. other nonoperating income (expense) for the quarter ending 2022-09-30 was -$470.00K, a 117.68% decline year-over-year.
- Allarity Therapeutics, Inc. other nonoperating income (expense) for fiscal 2021 was $41.00K, a 97.84% decline from fiscal 2020.
- Allarity Therapeutics, Inc. other nonoperating income (expense) for fiscal 2020 was $1.90M.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$21.00K 10-Q · filed 2023-11-14 | $1.75M derived: sum of 2 quarters · filed 2023-11-14 | $2.07M 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $1.78M 10-Q · filed 2023-08-14 | $2.09M 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | $307.00K 10-Q · filed 2023-05-11 | |||||
| 2022-09-30 | -$470.00K 10-Q · filed 2023-11-14 | -$727.00K derived: sum of 2 quarters · filed 2023-11-14 | $13.28M 10-Q · filed 2023-11-14 | $12.23M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$257.00K 10-Q · filed 2023-08-14 | $13.74M 10-Q · filed 2023-08-14 | $12.71M derived: sum of 3 quarters · filed 2023-08-14 | $15.36M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $14.00M 10-Q · filed 2023-05-11 | $12.96M derived: sum of 2 quarters · filed 2023-05-11 | $15.62M derived: sum of 3 quarters · filed 2023-05-11 | $14.63M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-17 | $1.62M derived: sum of 2 quarters · filed 2022-11-14 | $628.00K derived: sum of 3 quarters · filed 2022-11-14 | $41.00K 10-K · filed 2022-05-17 | ||
| 2021-09-30 | $2.66M 10-Q · filed 2022-11-14 | -$4.46M 10-Q · filed 2021-11-23 | $1.67M derived: sum of 2 quarters · filed 2022-11-14 | $1.08M 10-Q · filed 2022-11-14 | -$3.42M 10-Q · filed 2021-11-23 | $4.04M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$990.00K 10-Q · filed 2022-10-07 | -$1.58M 10-Q · filed 2022-10-07 | $1.38M derived: sum of 3 quarters · filed 2022-10-07 | $1.07M derived: sum of 4 quarters · filed 2022-10-07 | ||
| 2021-03-31 | -$590.00K 10-Q · filed 2022-05-27 | $2.37M derived: sum of 2 quarters · filed 2022-05-27 | $2.06M derived: sum of 3 quarters · filed 2022-05-27 | |||
| 2020-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-17 | $2.65M derived: sum of 2 quarters · filed 2022-05-17 | $1.90M 10-K · filed 2022-05-17 | |||
| 2020-09-30 | -$314.00K 10-Q · filed 2021-11-23 | -$1.06M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |